Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region

Abstract Background Due to the populations’ susceptibility, DENV-4 introduction in 2010 led to the occurrence of explosive epidemics in the following years in Brazil. In 2011, DENV-4 was identified in Rio de Janeiro (RJ) and it was prevalent in 2012 and 2013. Here, we aimed to characterize clinical,...

Full description

Bibliographic Details
Main Authors: Manoela Heringer, Thiara Manuele A Souza, Monique da Rocha Q Lima, Priscila Conrado G Nunes, Nieli Rodrigues da C Faria, Fernanda de Bruycker-Nogueira, Thaís Chouin-Carneiro, Rita Maria R Nogueira, Flavia Barreto dos Santos
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-017-2488-4
_version_ 1818600405179826176
author Manoela Heringer
Thiara Manuele A Souza
Monique da Rocha Q Lima
Priscila Conrado G Nunes
Nieli Rodrigues da C Faria
Fernanda de Bruycker-Nogueira
Thaís Chouin-Carneiro
Rita Maria R Nogueira
Flavia Barreto dos Santos
author_facet Manoela Heringer
Thiara Manuele A Souza
Monique da Rocha Q Lima
Priscila Conrado G Nunes
Nieli Rodrigues da C Faria
Fernanda de Bruycker-Nogueira
Thaís Chouin-Carneiro
Rita Maria R Nogueira
Flavia Barreto dos Santos
author_sort Manoela Heringer
collection DOAJ
description Abstract Background Due to the populations’ susceptibility, DENV-4 introduction in 2010 led to the occurrence of explosive epidemics in the following years in Brazil. In 2011, DENV-4 was identified in Rio de Janeiro (RJ) and it was prevalent in 2012 and 2013. Here, we aimed to characterize clinical, epidemiological and laboratorial aspects of DENV-4 cases after this serotype introduction in an endemic scenario. Methods Dengue suspected cases (n = 3727) were received and analyzed from January 2011 to December 2013, during outbreaks occurred in RJ, Brazil. Samples were submitted to virological, serological and molecular methods for case confirmation. DENV-4 cases (n = 705) were characterized according to the type of infection, disease severity and, viremia levels and NS1 antigenemia were accessed. Representative strains were partial sequenced for genotyping. Results DENV-4 was identified in 44.2% (705/1593) of dengue positive cases, virus isolated in 48.7% of the cases. Anti-DENV IgM was detected in 39.4% of the cases, however an increased detection was observed in cases with ≥4 days of symptoms (57.0%). NS1 antigen was identified in 41.5% of DENV-4 cases however, after immune complexes dissociation, the detection significantly increased (87.6%). Females were more affected than males, so did children aged 11–15 years old. Primary cases were more frequently observed than secondary ones and most of them were classified as dengue. No differences on NS1 antigenemia and viraemia within the groups were observed. Despite the higher frequency of severe disease on individuals >65 years old, no differences were observed among the groups and type of infection. However, DENV-4 fatal cases were more frequent on secondary infections (57.1%). DENV-4 Genotype II was identified with a probable origin from Venezuela and Colombia. Conclusions It has been shown that laboratorial diagnosis is still a reliable tool for the disease surveillance, detecting and confirming emerging epidemics. Despite the occurrence of secondary infections, most DENV-4 cases presented a mild disease. As RJ is endemic for dengue, high rates of secondary infections would be expected. Despite the existence of two genotypes, only Genotype II was identified in our study.
first_indexed 2024-12-16T12:34:58Z
format Article
id doaj.art-ea401401c081472baa7570e628cfea52
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-16T12:34:58Z
publishDate 2017-06-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-ea401401c081472baa7570e628cfea522022-12-21T22:31:36ZengBMCBMC Infectious Diseases1471-23342017-06-011711910.1186/s12879-017-2488-4Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic regionManoela Heringer0Thiara Manuele A Souza1Monique da Rocha Q Lima2Priscila Conrado G Nunes3Nieli Rodrigues da C Faria4Fernanda de Bruycker-Nogueira5Thaís Chouin-Carneiro6Rita Maria R Nogueira7Flavia Barreto dos Santos8Viral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZViral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZViral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZViral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZViral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZViral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZViral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZFlavivirus Laboratory, Oswaldo Cruz InstituteViral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZAbstract Background Due to the populations’ susceptibility, DENV-4 introduction in 2010 led to the occurrence of explosive epidemics in the following years in Brazil. In 2011, DENV-4 was identified in Rio de Janeiro (RJ) and it was prevalent in 2012 and 2013. Here, we aimed to characterize clinical, epidemiological and laboratorial aspects of DENV-4 cases after this serotype introduction in an endemic scenario. Methods Dengue suspected cases (n = 3727) were received and analyzed from January 2011 to December 2013, during outbreaks occurred in RJ, Brazil. Samples were submitted to virological, serological and molecular methods for case confirmation. DENV-4 cases (n = 705) were characterized according to the type of infection, disease severity and, viremia levels and NS1 antigenemia were accessed. Representative strains were partial sequenced for genotyping. Results DENV-4 was identified in 44.2% (705/1593) of dengue positive cases, virus isolated in 48.7% of the cases. Anti-DENV IgM was detected in 39.4% of the cases, however an increased detection was observed in cases with ≥4 days of symptoms (57.0%). NS1 antigen was identified in 41.5% of DENV-4 cases however, after immune complexes dissociation, the detection significantly increased (87.6%). Females were more affected than males, so did children aged 11–15 years old. Primary cases were more frequently observed than secondary ones and most of them were classified as dengue. No differences on NS1 antigenemia and viraemia within the groups were observed. Despite the higher frequency of severe disease on individuals >65 years old, no differences were observed among the groups and type of infection. However, DENV-4 fatal cases were more frequent on secondary infections (57.1%). DENV-4 Genotype II was identified with a probable origin from Venezuela and Colombia. Conclusions It has been shown that laboratorial diagnosis is still a reliable tool for the disease surveillance, detecting and confirming emerging epidemics. Despite the occurrence of secondary infections, most DENV-4 cases presented a mild disease. As RJ is endemic for dengue, high rates of secondary infections would be expected. Despite the existence of two genotypes, only Genotype II was identified in our study.http://link.springer.com/article/10.1186/s12879-017-2488-4Dengue virus type 4Laboratorial diagnosisPhylogenyEndemicRio de JaneiroBrazil
spellingShingle Manoela Heringer
Thiara Manuele A Souza
Monique da Rocha Q Lima
Priscila Conrado G Nunes
Nieli Rodrigues da C Faria
Fernanda de Bruycker-Nogueira
Thaís Chouin-Carneiro
Rita Maria R Nogueira
Flavia Barreto dos Santos
Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region
BMC Infectious Diseases
Dengue virus type 4
Laboratorial diagnosis
Phylogeny
Endemic
Rio de Janeiro
Brazil
title Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region
title_full Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region
title_fullStr Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region
title_full_unstemmed Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region
title_short Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region
title_sort dengue type 4 in rio de janeiro brazil case characterization following its introduction in an endemic region
topic Dengue virus type 4
Laboratorial diagnosis
Phylogeny
Endemic
Rio de Janeiro
Brazil
url http://link.springer.com/article/10.1186/s12879-017-2488-4
work_keys_str_mv AT manoelaheringer denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion
AT thiaramanueleasouza denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion
AT moniquedarochaqlima denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion
AT priscilaconradognunes denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion
AT nielirodriguesdacfaria denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion
AT fernandadebruyckernogueira denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion
AT thaischouincarneiro denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion
AT ritamariarnogueira denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion
AT flaviabarretodossantos denguetype4inriodejaneirobrazilcasecharacterizationfollowingitsintroductioninanendemicregion